Clinical Nutrition Market: Trends, Share & Growth Forecasts (2026-2031)

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Clinical Nutrition - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The clinical nutrition market is poised for substantial growth, with estimations reaching USD 84.31 billion in 2026, expanding from USD 78.11 billion in 2025. Projections for 2031 indicate a significant growth to USD 123.54 billion, driven by a robust CAGR of 7.94% from 2026 to 2031. A surge in metabolic disorders such as diabetes and dysphagia is fostering the expansion of the clinical nutrition market. These specialized formulations are increasingly essential for meeting nutritional needs, enhancing recovery, and improving health outcomes. The burgeoning demand is notably evident within the geriatric sector and the oncology field, where cancer cases are rising, necessitating the inclusion of dietitians in treatment planning. Specialized formulas play a critical role in multidisciplinary treatment approaches, presenting lucrative opportunities for manufacturers in the clinical nutrition arena. Home-Based Enteral Feeding in Post-Acute Care The healthcare landscape is shifting towards home enteral nutrition, a trend driven by hospitals aiming to minimize patient stays without compromising care quality. A study published in BMC Surgery (December 2024) explored varying energy levels in supplementary parenteral nutrition for gastric cancer patients, revealing correlations between energy intake, recovery speed, complication rates, and overall health. These insights are prompting innovations in nutritional strategies, particularly personalized solutions that bolster patient recovery and outcomes. Adoption of Immunonutrition Formulas for Post-Surgery Recovery The Journal of Surgery (December 2023) identified perioperative blends incorporating arginine, glutamine, and omega-3s as instrumental in reducing complications post-major abdominal surgeries. Automated prompts in electronic admission checklists are now recommending these nutritional products, enhancing their significance alongside antibiotic prophylaxis. As procurement officers underscore product access linked to clinical outcomes, the clinical nutrition market is witnessing increased demand and growth. Suppliers are co-sponsoring surgery registries to expedite evidence generation, gaining a competitive edge. Regulatory Challenges Comprehensive safety and efficacy standards imposed by the U.S. FDA and the European Food Safety Authority are pivotal for novel clinical nutrition products. Preparing submission-ready files is resource-intensive, often necessitating collaborations between emerging entrants and established manufacturers. These partnerships leverage experienced regulatory teams, which may trade expertise for equity stakes, making regulatory proficiency a competitive asset under investor scrutiny. Market Drivers and Restraints Government-Funded Pediatric Malnutrition Programs Limited Insurance Coverage for Out-of-Hospital Parenteral Nutrition Segment Analysis By 2025, oral and enteral nutrition will dominate with a 69.15% market share, underscoring its leading role when gastrointestinal functionality permits. In contrast, parenteral nutrition is anticipated to grow rapidly, with a CAGR of 8.42% from 2026 to 2031, driven by its expanding adoption in critical care and oncology. Advances in lipid emulsions, including omega-3-rich fish oils, are further fueling this growth through clinical benefits such as reduced infection rates and shorter hospital stays. In 2025, infant nutrition products will account for a 44.12% market share. However, disease-specific enteral formulas are projected to grow at an 8.98% CAGR by 2031. Government initiatives aimed at enhancing infant health and nutrition are increasing the availability and accessibility of tailored formulations. This, in turn, is boosting awareness and compliance among caregivers. Notably, the Philippine Plan of Action for Nutrition (PPAN) 2023-2028 is a prime example of strategic frameworks driving demand. The clinical nutrition market spans numerous segments including Route of Administration, Product Type, Form, Application, End User, Distribution Channel, and Geography. Value-based market sizes and forecasts offer comprehensive insights. Geographical Analysis Chronic illnesses account for nearly 90% of the U.S.'s USD 4.5 trillion healthcare expenditure. This economic burden is prompting payer organizations to reimburse disease-specific nutrition formulas, instrumental in mitigating costly medical interventions. The prevalent cost of heart disease, stroke, and diabetes underscores the need for nutritional interventions emphasizing amino-acid ratios and glycemic indices, realigning formulary reviews around metabolic health. Germany's March 2024 initiatives under the "Good Food for Germany" strategy highlight Europe's sophisticated market landscape, marked by rigorous regulatory standards and clinical guidelines. This environment is conducive to growth within the clinical nutrition market. The Asia-Pacific region presents lucrative opportunities amid escalating health awareness and governmental policies fostering nutrition education. Initiatives focusing on food safety and nutrition for vulnerable populations, such as TB patients, illustrate the regional push toward comprehensive nutritional solutions. Companies Covered: Abbott Laboratories Nestle Fresenius Baxter Danone B. Braun Perrigo Company Reckitt Benckiser Group Ajinomoto Cambrooke AYMES International Medifood International Kate Farms Key Topics Covered 1 Introduction 1.1 Study Assumptions & Market Definition 1.2 Scope of the Study 2 Research Methodology 3 Executive Summary 4 Market Landscape 4.1 Market Overview 4.2 Market Drivers 4.3 Market Restraints 4.4 Value Chain Analysis 4.5 Regulatory Outlook 4.6 Technological Outlook 4.7 Porter's Five Forces Analysis 4.8 Clinical Trial Landscape 5 Market Size & Growth Forecasts (Value, USD) 5.1 By Route of Administration 5.2 By Product Type 5.3 By Form 5.4 By Application 5.5 By End User 5.6 By Distribution Channel 5.7 Geography 6 Competitive Landscape 6.1 Market Concentration 6.2 Market Share Analysis 6.3 Company Profiles 7 Market Opportunities & Future Outlook 7.1 White-Space & Unmet-Need Assessment For more information about this report visit https://www.researchandmarkets.com/r/goa9h9 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.